The Queen Elizabeth Hospital is a 243-bed acute care hospital located in Charlottetown, Prince Edward Island, Canada, making it the largest hospital in the province. Operated by Health PEI, the hospital opened in 1982, resulting in the closure of the Charlottetown Hospital and the Prince Edward Island Hospital.

During the past decade, Queen Elizabeth Hospital, PEI conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Elizabeth Hospital, PEI" #1 sponsor was "NCIC Clinical Trials Group" with 8 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "AGO Study Group" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Novartis Vaccines" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Hospital, PEI" #1 collaborator was "NCIC Clinical Trials Group" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Dalhousie University" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "The Queen Elizabeth Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Hospital, PEI" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (2 trials), "Ovarian Cancer" (2 trials) and "Anorexia" (1 trials). Many other conditions were trialed in "Queen Elizabeth Hospital, PEI" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth Hospital, PEI" are "Drug" (12 trials), "Behavioral" (2 trials), "Biological" (2 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "prednisone" (3 trials), "alvocidib" (2 trials), "gemcitabine hydrochloride" (2 trials), "mitoxantrone hydrochloride" (2 trials) and "tamoxifen citrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth Hospital, PEI" are 10 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Queen Elizabeth Hospital, PEI". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Queen Elizabeth Hospital, PEI, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth Hospital, PEI, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".